Thomas Eschenhagen - Curriculum Vitae#

• 1978-1986 Hannover Medical School (MHH), degree physician
  
• 1988 Medical thesis (PhD equivalent) Hannover Medical School
  
• 1992 Molecular Biology Diploma, University of Hamburg
  
• 1994 Habilitation, University of Hamburg
  
• 1995 Approval as specialist in Pharmacology and Toxicology, Physician´s Board Hamburg
  
• 1997 Approval as specialist in Clinical Pharmacology, Physician´s Board Hamburg
  
• 1994-1998 Heisenberg grant DFG, Visiting scientist in Washington University, St. Louis, USA, Stanford Research Center, Menlo Park, USA, National Institute of Ageing, NIH, Baltimore, USA, Universite Paris 11, INSERM U-446, Chatenay Malabry, France

• 2000-2002 Coordinator and speaker, DFG Graduate School 750, University of Erlangen "Vascular damage in kidney and heart"
  
• 2005-2011 Coordinator and speaker, DFG Research Group FOR 604 "Signaling pathways in the healthy and diseased heart", University of Hamburg
  
• 2004-2009 Core member Fondation LeDucq Transatlantic Networks of Excellence "Cardiac Progenitors Transatlantic Alliance" (ccordinators K. Schwartz, K. Chien)
  
• 2015-2019 German Centre for Cardiovascular Research DZHK, Partner site Hamburg/Kiel/Lübeck, PI Eschenhagen
  
• 2013-2017 British Heart Foundation (coordinator S. Harding, ICL, UK) Regenerative Medicine Centres, PI Eschenhagen
  
• 2013-2019 ERC AG "IndivuHeart - individualized risk assessment with hiPSC-derived engineered heart tissue"
  
• 2014-2017 British National Centre for the Reduction of Animal Experiments (NCR) CRACK-IT Challenges "Engineered 2D & 3D hiPSC-CM platforms to detect cardiovascular safety liabilities (coordinator C. Denning, Nottingham, UK), PI Eschenhagen
  
• 2016-2018 EU Horizon 2020 ITN "Atrial Fibrillation (coordinator T. Jespersen, Kopenhagen, DK), PI Christ and Eschenhagen
  
• 2017-2020 ERA-CVD "Variation" (coordinator Y. Pinto, Amsterdam, NL), PI Eschenhagen

• Board member German Heart Association (2003), German Association for Chronic Diseases (2005), Galenus von Pergamon *Award Committee (2012), German Physician´s Drug Commission (2008), European Society of Cardiology Heart Failure Association (2006-2012)
  
• Editorial Board membership J Mol Cell Cardiol; Bas Res Cardiol, Clin Res Cardiol, Cardiovasc Res (Associate Editor 20014-2016)
  
• Associate Editor, Circulation (since 2016)
  
• 2004-2012 Member DFG Selection panel for Cardiovascular Research
  
• 2012-2017 Member DFG Selection panel for Collaborative Research Centers (SFB)
  
• Reviewer for British Heart Foundation (e.g. Excellence Centres), Netherlands Academy of Science (ICIN Evaluation), Austrian Science Board, INSERM and others
  
• 2004 Organizer of EU Workshop on "The Future of Young Scientists in Cardiovascular Research"
  
• Since 2006 Organizer/coorganizer of the ESC-HFA Winter Meeting on Translational Heart Failure Research)
  
• 2006 Member of roadmap procedures for the NIH (stem cells) and the German Ministry of Education and Research (BMBF) and the EU
  
• 2008-2012 Speaker of the Scientific Advisory Board of the Leibniz Institute of Arteriosclerosis Research (LIFA) in Münster
  
• Speaker DZHK (since 2011)
  
• 2017 Coorganizer of the Annual Meeting of the ISHR European Section, Hamburg (main organizer L. Carrier)
  
• 2018 Coorganizer of the Gordon Research Conference on Cardiac Regulatory Mechanisms
  
• 2018 President of the Annual Meeting of the German Society for Cardiology (DGK, Mannheim)